We are live on ! Find out more
WVE icon

Wave Life Sciences

81 hedge funds and large institutions have $95.4M invested in Wave Life Sciences in 2022 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 21 increasing their positions, 33 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

170% more call options, than puts

Call options by funds: $62K | Put options by funds: $23K

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

2% less capital inflows, than outflows

Capital inflows: $8.81M | Capital outflows: $8.96M

2.02% less ownership

Funds ownership: 80.4% → 78.38% (-2%)

10% less funds holding

Funds holding: 90 → 81 (-9)

36% less repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 33

59% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 17

Holders
81
Holders Change
-9
Holders Change %
-10%
% of All Funds
1.27%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
7
Increased
21
Reduced
33
Closed
17
Calls
$62​K
Puts
$23​K
Net Calls
+$39​K
Net Calls Change
-⁠$78​K

WVE Hedge Fund Activity: Q1 2022 in Review

81 of the 6,363 institutional investors tracked by Wall St. Rank reported a position in Wave Life Sciences (WVE) for Q1 2022, worth a combined $95.4M — down 36% from $149M a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of WVE and 7 opened new positions — a net loss of 10 holders — while 33 trimmed existing stakes and 21 added.

The largest buyer was M28 Capital Management, adding an estimated $5.11M. The largest seller was Logos Global Management, exiting entirely with an estimated $2.51M sold.

  • 81 institutional investors held Wave Life Sciences (WVE) as of Q1 2022, down from 90 in Q4 2021.
  • Funds reported $95.4M of Wave Life Sciences stock for Q1 2022, down 36% quarter-over-quarter.
  • 7 funds opened new Wave Life Sciences positions in Q1 2022 and 17 closed out, a net change of -10 holders.
  • The largest Wave Life Sciences buyer in Q1 2022 was M28 Capital Management, an estimated $5.11M added.
  • The largest Wave Life Sciences seller in Q1 2022 was Logos Global Management, an estimated $2.51M sold.

Based on aggregated 13F filings for Q1 2022.